Therapeutic effect of low dose tolvaptan combined with furosemide in elderly patients with chronic heart failure and diuretic resistance
10.3969/j.issn.1009-0126.2018.02.012
- VernacularTitle:托伐普坦联合呋塞米治疗老年慢性心力衰竭利尿剂抵抗患者的疗效观察
- Author:
Lili WANG
1
;
Yanping GENG
;
Qian YANG
;
Xiuhong YANG
;
Rongpin DU
Author Information
1. 河北省人民医院心内科
- Keywords:
heart failure;
furosemide;
diuretics;
body mass index;
natriuretic peptide,brain;
urine
- From:
Chinese Journal of Geriatric Heart Brain and Vessel Diseases
2018;20(2):158-160
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the therapeutic effect of low dose tolvaptan combined with furosemide in ederly patients with CHF and diuretic resistance (DR).Methods Eighty-five elderly patients with CHF and DR were divided into observation group (n=43) and control group (n=42).The patients in observation group were treated with cardiotonics and hypotensors plus oral tolvaptan (15 mg/d) combined with intravenous furosemide (40 mg/d).The therapeutic effect of low dose tolvaptan combined with furosemide was assessed.Results The average urinary volume was larger,and the LVEDV was significantly lower in two groups after treatment than before treatment (P＜0.05).The urinary volume was significantly larger while the LVEDV was significantly lower in observation group than in control group (2.89±0.87 L/d vs 2.43±0.49 L/d,P=0.01;103.6±21.5 ml vs 116.7±24.3 ml,P=0.01).The total effective rate was significantly higher in observation group than in control group (86.0％ vs 71.4％,P=0.01).Conclusion Low dose tolvaptan combined with furosemide can effectively improve the DR and therapeutic effect in elderly CHF patients,and is thus worth popularization in clinical practice.
